News

• 22 May, 2026
  Spago Nanomedical beslutar om en företrädesemission om cirka 16 MSEK
• 22 May, 2026
  Spago Nanomedical resolves on a rights issue of approximately SEK 16 million
• 19 May, 2026
  Spago Nanomedical publicerar årsredovisningen för 2025
• 19 May, 2026
  Spago Nanomedical publishes the annual report for 2025
• 18 May, 2026
  Spago Nanomedical presenterar kliniska data för Tumorad® vid den internationella ANZSNM-konferensen 2026
• 18 May, 2026
  Spago Nanomedical presents Tumorad® clinical data at the international ANZSNM 2026 conference
• 11 May, 2026
  KALLELSE TILL ÅRSSTÄMMA I SPAGO NANOMEDICAL AB (PUBL)
• 11 May, 2026
  NOTICE TO ANNUAL GENERAL MEETING OF SPAGO NANOMEDICAL AB (PUBL)
• 7 May, 2026
  Spago Nanomedical delårsrapport januari-mars 2026
• 7 May, 2026
  Spago Nanomedical interim report January-March 2026